Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Search Results
Search Results 2641 – 2660 of 3231
Recognizing and Managing Antiretroviral Treatment Failure
https://clinicalinfo.hiv.gov/node/9463
Malaria
https://clinicalinfo.hiv.gov/node/9464
What's New in the Guidelines
https://clinicalinfo.hiv.gov/node/9465
Immunizations for Preventable Diseases in Adults and Adolescents With HIV
https://clinicalinfo.hiv.gov/node/9466
Delavirdine (Rescriptor, DLV)
https://clinicalinfo.hiv.gov/node/9468
Etravirine
https://clinicalinfo.hiv.gov/node/9469
Gastrointestinal Effects
https://clinicalinfo.hiv.gov/node/9470
Atazanavir (Reyataz, ATV)
https://clinicalinfo.hiv.gov/node/9471
Nelfinavir (Viracept, NFV)
https://clinicalinfo.hiv.gov/node/9472
Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview
https://clinicalinfo.hiv.gov/node/9473
Appendix B: Web-Based Resources for Treating and Preventing HIV
https://clinicalinfo.hiv.gov/node/9474
Dyslipidemia
https://clinicalinfo.hiv.gov/node/9475
Table 4. Common Drugs Used for Treatment of Opportunistic Infections in Children With HIV: Preparations and Major Toxicities
https://clinicalinfo.hiv.gov/node/9476
Tenofovir AF
https://clinicalinfo.hiv.gov/node/9477
Modifying Antiretroviral Regimens in Children With Sustained Virologic Suppression on Antiretroviral Therapy
https://clinicalinfo.hiv.gov/node/9478
Abacavir (Ziagen, ABC)
https://clinicalinfo.hiv.gov/node/9479
Rilpivirine
https://clinicalinfo.hiv.gov/node/9480
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2025
https://clinicalinfo.hiv.gov/node/9481
Tipranavir
https://clinicalinfo.hiv.gov/node/9482
What’s New in the Guidelines
https://clinicalinfo.hiv.gov/node/9484

Paginación

  • Primera página «
  • Página anterior ‹
  • …
  • Página 129
  • Página 130
  • Página 131
  • Página 132
  • Página actual 133
  • Página 134
  • Página 135
  • Página 136
  • Página 137
  • …
  • Siguiente página ›
  • Última página »

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.